Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes

Drug Metabolism Reviews

Volumn 34, Issue 1-2, 2002, Pages 17-35

  Hollenberg, Paul F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

CATALYSIS; COMPETITIVE INHIBITION; DRUG METABOLISM; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SUBSTRATE; PROTEIN DEGRADATION; REVIEW;

CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATORS; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS;

EID: 0036226707     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120001387     Document Type: Review

References (63)

1. Inhibition and induction of cytochrome P450 and the clinical implications
2. A fatal drug interaction between clozapine and fluoxetine
3. Death attributed to the toxic interaction of triazolam, amitryptyline and other psychotropic drugs
4. Oxygen activation by cytochrome P450
5. Inhibition of cytochrome P450 enzymes
6. Inhibition of drug metabolizing enzymes: Molecular and biochemical aspects
7. Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: Involvement of enzyme inactivation
8. Virtual kinetics: Using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms
9. Pharmacokinetics in toxicology
10. A metabolically based drug interaction: In vivo studies
11. Substrate interactions with cytochrome P-450
12. Oxidation-reduction properties of rat liver cytochromes P450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems
13. The enzymic formation of a methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes
14. Studies on the interaction of safrole with rat hepatic microsomes
15. Selective inhibitory interactions of alkoxymethylene-dioxybenzenes towards mono-oxygenase activity in rat hepatic microsomes
16. Nitrosoalkanes as Fe(II) ligands in the 455-nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing conditions
17. Mechanism-based (suicide) enzyme inactivation
18. Mechanism-based inactivators as probes of cytochrome P450 structure and function
19. Inactivation of P450 3A4 by bergamottin, a component of grapefruit juice
20. Suicide substrates for the alanine racemase of Eschericia coli B
21. Induction of cytochrome P450 enzymes that metabolize xenobiotics
22. Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture
23. The metabolism of methylated aminoazo dyes. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene
24. Induction of human drug-metabolizing enzymes: Mechanisms and implications
25. Sterospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: Evidence that the binding species is a receptor for the induction of aryl hydrocarbon hydroxylase
26. Association of the Ah receptor with the 90 kDa heat shock protein
27. A genetic analysis of processes regulating cytochrome P450 1A1 expression
28. Glucocorticoid regulation of the rat cytochrome P450c (P4501A1) gene: Receptor binding within intron I
29. In vitro binding and functional studies comparing human CYP1A1 regulatory element with the orthologous sequences from rodent genes
30. Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence
31. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA which supports Ah receptor binding and promotor specific induction
32. Phenobarbital induction of cytochrome P-450 gene expression
33. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR
34. Regulation of cytochrome P450 (CYP) genes by nuclear receptors
35. The CYP2E family
36. Evidence for increased translational efficiency in the induction of P450 IIE1 by solvents: Analysis of P450 IIE1 mRNA polyribosomal distribution
37. Induction of P450 2E1 in isolated rabbit hepatocytes: Role of increased protein and mRNA synthesis
38. Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 Cell model by ethanol
39. The increase in urinary excretion of 6(-hydroxycortisol) as a marker of human hepatic cytochrome P450IIIA induction
40. Identification of rifampicin-inducible P450IIA4 (CYP3A4) in human small bowel enterocytes
41. Gut wall metabolism of verapamil in older people: Effects of rifampicin-mediated enzyme induction
42. Rifampicin drastically reduces plasma concentrations and effects of oral midazolam
43. Bioavailability of cyclosporin with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction
44. Enhanced cyclophosphamide and ifosphamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines
45. Enhancement and inhibition of microsomal drug metabolism
46. Agents activating the liver microsomal mixed function oxidase system
47. The role of the stimulation of NADPH-cytochrome P-450 reductase activity in hepatic, microsomal mixed function oxidase activity
48. Effects of metyrapone on liver microsomal drug oxidations
49. Acetone enhancement of microsomal aniline para-hydroxylase activity
50. Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes
51. Oxidation of benzo[a]pyrene by recombinant cytochrome P450 enzymes
52. Cooperativity in oxidations catalyzed by cytochrome P450 3A
53. Cytochrome P-450 3A4: Regulation and role in drug metabolism
54. Autoactivation and activation of the cytochrome P450s
55. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions
56. Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids
57. Analysis of human cytochrome P450 3A4 cooperativity. Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics
58. Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites
59. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity
60. Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics